Published on 14 Feb 2023 on Simply Wall St. via Yahoo Finance
Key Insights
Significant insider control over Nautilus Biotechnology implies vested interests in company growthA total of 6 investors have a majority stake in the company with 54% ownership 23% of Nautilus Biotechnology is held by Institutions
Every investor in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) should be aware of the most powerful shareholder groups. With 33% stake, individual insiders possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).